The Children’s Heart Centre is a passionate team of clinicians, researchers, medical trainees, and technical and clerical staff. We are committed to producing high-quality research to improve care for children with cardiovascular conditions.
Our team is focused on investigating use of virtual reality technology in pediatrics and providing evidenced based answers to help clinicians and health practitioners determine how to best use this innovative technology for everyday use.
The Injury Research Program led by Dr. Mariana Brussoni focuses on understanding injuries in children and youth, and measuring the physical, psychosocial and financial impacts of injuries on children, their families and the health care system.
The International Hip Dysplasia (IHDR) study group is an international collaboration of surgeons and medical professionals dedicated to improving the lives of children with hip dysplasia. With 23 worldwide sites and growing, IHDR aims to optimize patient care in health care systems around the world through research, education, and advocacy efforts.
Our research team, led by Dr. Louise Mâsse, aims to understand the factors in the school, social and home environments that influence children’s and teens’ health behaviours, specifically, physical activity, screen time and nutrition.
The vision of the Department of Pediatric Anesthesia at BC Children's Hospital is to provide excellence and innovation in patient-centered care for the children and their families of British Columbia. Evaluation, improvement, and innovation are key research activities that allow us to optimize the clinical care we provide.
The SEARCH team evaluates drug safety and effectiveness and identifies risks associated with commonly prescribed drugs; PREVENT uses pharmacogenomics discovery and replication (in at least three independent populations) to identify strongly-predictive pharmacogenomic biomarkers.
BC Children’s Hospital houses the only Sleep Laboratory in the province of BC, where a multidisciplinary team provides diagnostic assessment and treatment for children and youth across BC, and conducts research to advance sleep medicine.
A new study led by researchers from the BC Injury Research and Prevention Unit found girls in rural B.C. communities with poor access to local mental health services are at the highest risk of intentionally poisoning themselves. The most common substance used was non-opioid painkillers and the second most common substance used was medication for anxiety and depression.
Dr. Pascal Lavoie and his team compared the immune responses of babies to those of COVID-19-negative adults from Metro Vancouver. The antibody reactivity to SARS-CoV-2 in almost all of these adults was up to 100-fold higher compared to the infants at second blood sera collection. The researchers estimate that between 90-99 per cent of adults have positive antibody reactivity to SARS-CoV-2 antigens.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.